$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Dendritic cell recruitment and activation in autoimmunity

Journal of autoimmunity, v.85, 2017년, pp.126 - 140  

Sozzani, Silvano (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy) ,  Del Prete, Annalisa (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy) ,  Bosisio, Daniela (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy)

Abstract AI-Helper 아이콘AI-Helper

Abstract Dendritic cells (DCs) are professional antigen presenting cells displaying the unique capability to activate naïve T cells. DCs react to pathogen encounter also by the production of mediators of inflammation, including pro-inflammatory cytokines. Because of this complex role, any imba...

참고문헌 (256)

  1. Annu. Rev. Immunol. Steinman 30 1 2012 10.1146/annurev-immunol-100311-102839 Decisions about dendritic cells: past, present, and future 

  2. Science Villani 356 2017 10.1126/science.aah4573 Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors 

  3. Science See 356 2017 10.1126/science.aag3009 Mapping the human DC lineage through the integration of high-dimensional techniques 

  4. Annu. Rev. Immunol. Murphy 34 93 2016 10.1146/annurev-immunol-032713-120204 Transcriptional control of dendritic cell development 

  5. Proc. Natl. Acad. Sci. U. S. A. Knight 80 6032 1983 10.1073/pnas.80.19.6032 Induction of immune responses in vivo with small numbers of veiled (dendritic) cells 

  6. Nat. Rev. Immunol. Ganguly 13 566 2013 10.1038/nri3477 The role of dendritic cells in autoimmunity 

  7. Front. Immunol. Guery 4 59 2013 10.3389/fimmu.2013.00059 Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity 

  8. Nat. Immunol. Satpathy 13 1145 2012 10.1038/ni.2467 Re(de)fining the dendritic cell lineage 

  9. Immunity Onai 38 943 2013 10.1016/j.immuni.2013.04.006 A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential 

  10. Cell Cisse 135 37 2008 10.1016/j.cell.2008.09.016 Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development 

  11. Immunity Ghosh 33 905 2010 10.1016/j.immuni.2010.11.023 Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells 

  12. Blood Schlitzer 117 6562 2011 10.1182/blood-2010-12-326678 Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs 

  13. Blood Schlitzer 119 6063 2012 10.1182/blood-2012-03-418400 Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor 

  14. Nat. Immunol. Hacker 4 380 2003 10.1038/ni903 Transcriptional profiling identifies Id2 function in dendritic cell development 

  15. J. Exp. Med. Spits 192 1775 2000 10.1084/jem.192.12.1775 Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2 

  16. Blood Li 120 4363 2012 10.1182/blood-2012-07-441311 The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development 

  17. Nat. Rev. Immunol. Swiecki 15 471 2015 10.1038/nri3865 The multifaceted biology of plasmacytoid dendritic cells 

  18. Blood Marafioti 111 3778 2008 10.1182/blood-2007-10-117531 Novel markers of normal and neoplastic human plasmacytoid dendritic cells 

  19. Nat. Med. Cella 5 919 1999 10.1038/11360 Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon 

  20. Science Siegal 284 1835 1999 10.1126/science.284.5421.1835 The nature of the principal type 1 interferon-producing cells in human blood 

  21. Blood Ito 107 2423 2006 10.1182/blood-2005-07-2709 Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells 

  22. Immunol. Rev. Pestka 202 8 2004 10.1111/j.0105-2896.2004.00204.x Interferons, interferon-like cytokines, and their receptors 

  23. Immunity van Boxel-Dezaire 25 361 2006 10.1016/j.immuni.2006.08.014 Complex modulation of cell type-specific signaling in response to type I interferons 

  24. Curr. Top. Microbiol. Immunol. Uze 316 71 2007 The receptor of the type I interferon family 

  25. Curr. Pharm. Des. Deonarain 8 2131 2002 10.2174/1381612023393288 Interferon-alpha/beta-receptor interactions: a complex story unfolding 

  26. J. Interferon Res. Overall 12 281 1992 10.1089/jir.1992.12.281 Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells 

  27. Proc. R. Soc. Lond. Ser. B, Biol. Sci. Isaacs 147 258 1957 Virus interference. I. The interferon 

  28. Biochimie Fitzgerald-Bocarsly 89 843 2007 10.1016/j.biochi.2007.04.018 The role of type I interferon production by dendritic cells in host defense 

  29. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Hervas-Stubbs 17 2619 2011 10.1158/1078-0432.CCR-10-1114 Direct effects of type I interferons on cells of the immune system 

  30. Cytokine & Growth Factor Rev. Ferrantini 19 93 2008 10.1016/j.cytogfr.2007.10.003 Dendritic cells and cytokines in immune rejection of cancer 

  31. J. Immunol. Ito 166 2961 2001 10.4049/jimmunol.166.5.2961 Differential regulation of human blood dendritic cell subsets by IFNs 

  32. J. Immunol. Luft 161 1947 1998 10.4049/jimmunol.161.4.1947 Type I IFNs enhance the terminal differentiation of dendritic cells 

  33. Eur. J. Immunol. Lapenta 36 2046 2006 10.1002/eji.200535579 IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens 

  34. Autoimmunity Rizza 43 204 2010 10.3109/08916930903510880 Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity 

  35. Nat. Immunol. Andoniou 6 1011 2005 10.1038/ni1244 Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity 

  36. Blood Rothenfusser 103 2162 2004 10.1182/blood-2003-04-1091 CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro 

  37. J. Exp. Med. Brinkmann 178 1655 1993 10.1084/jem.178.5.1655 Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells 

  38. Immunity Le Bon 14 461 2001 10.1016/S1074-7613(01)00126-1 Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo 

  39. Immunol. Rev. Bogdan 202 33 2004 10.1111/j.0105-2896.2004.00207.x The role of type I interferons in non-viral infections 

  40. Lupus Bengtsson 9 664 2000 10.1191/096120300674499064 Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies 

  41. J. Immunol. Dikopoulos 174 99 2005 10.4049/jimmunol.174.1.99 Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells 

  42. J. Immunol. Howes 197 2838 2016 10.4049/jimmunol.1501923 Differential production of type I IFN determines the reciprocal levels of IL-10 and proinflammatory cytokines produced by C57BL/6 and BALB/c macrophages 

  43. Transl. Res. J. Lab. Clin. Med. Crow 165 296 2015 Targeting of type I interferon in systemic autoimmune diseases 

  44. Cytokine & Growth Factor Rev. Gresser 13 111 2002 10.1016/S1359-6101(01)00035-1 Endogenous type I interferons as a defense against tumors 

  45. Eur. J. Immunol. Jarrossay 31 3388 2001 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells 

  46. J. Exp. Med. Kadowaki 194 863 2001 10.1084/jem.194.6.863 Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens 

  47. J. Immunol. Hornung 168 4531 2002 10.4049/jimmunol.168.9.4531 Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides 

  48. Nat. Immunol. Kawai 11 373 2010 10.1038/ni.1863 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors 

  49. Science Diebold 303 1529 2004 10.1126/science.1093616 e Sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA 

  50. Science Heil 303 1526 2004 10.1126/science.1093620 Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 

  51. Proc. Natl. Acad. Sci. U. S. A. Lund 101 5598 2004 10.1073/pnas.0400937101 Recognition of single-stranded RNA viruses by Toll-like receptor 7 

  52. Nature Hemmi 408 740 2000 10.1038/35047123 A Toll-like receptor recognizes bacterial DNA 

  53. Immunity Haas 28 315 2008 10.1016/j.immuni.2008.01.013 The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation 

  54. Nat. Immunol. Barton 7 49 2006 10.1038/ni1280 Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA 

  55. Immunity Blasius 32 305 2010 10.1016/j.immuni.2010.03.012 Intracellular toll-like receptors 

  56. Biochimie Haller 89 812 2007 10.1016/j.biochi.2007.04.015 Interferon-induced Mx proteins in antiviral host defense 

  57. Nature Honda 434 1035 2005 10.1038/nature03547 Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction 

  58. J. Exp. Med. Guiducci 203 1999 2006 10.1084/jem.20060401 Properties regulating the nature of the plasmacytoid dendritic cell response to toll-like receptor 9 activation 

  59. J. Immunol. Kumagai 182 3960 2009 10.4049/jimmunol.0804315 Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells 

  60. Annu. Rev. Immunol. Reizis 29 163 2011 10.1146/annurev-immunol-031210-101345 Plasmacytoid dendritic cells: recent progress and open questions 

  61. J. Mol. Med. Kwidzinski 85 1351 2007 10.1007/s00109-007-0229-7 IDO expression in the brain: a double-edged sword 

  62. J. Exp. Med. Ito 204 105 2007 10.1084/jem.20061660 Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand 

  63. Immunity Durai 45 719 2016 10.1016/j.immuni.2016.10.010 Functions of murine dendritic cells 

  64. Autoimmun. Rev. Jimenez-Dalmaroni 15 1 2016 10.1016/j.autrev.2015.08.009 The critical role of toll-like receptors-From microbial recognition to autoimmunity: a comprehensive review 

  65. Science Fogg 311 83 2006 10.1126/science.1117729 A clonogenic bone marrow progenitor specific for macrophages and dendritic cells 

  66. Annu. Rev. Immunol. Merad 31 563 2013 10.1146/annurev-immunol-020711-074950 The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting 

  67. Mucosal Immunol. Sichien 10 831 2017 10.1038/mi.2017.8 Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues 

  68. Nat. Rev. Immunol. Guilliams 14 571 2014 10.1038/nri3712 Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny 

  69. Immunity Guilliams 45 669 2016 10.1016/j.immuni.2016.08.015 Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species 

  70. Science Hildner 322 1097 2008 10.1126/science.1164206 Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity 

  71. Nat. Immunol. Grajales-Reyes 16 708 2015 10.1038/ni.3197 Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor 

  72. Immunity Sichien 45 626 2016 10.1016/j.immuni.2016.08.013 IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively 

  73. J. Immunol. Bajana 189 3368 2012 10.4049/jimmunol.1102613 IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation 

  74. Immunity Persson 38 958 2013 10.1016/j.immuni.2013.03.009 IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation 

  75. Immunity Schlitzer 38 970 2013 10.1016/j.immuni.2013.04.011 IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses 

  76. Adv. Immunol. Haniffa 120 1 2013 10.1016/B978-0-12-417028-5.00001-6 Ontogeny and functional specialization of dendritic cells in human and mouse 

  77. J. Exp. Med. Jongbloed 207 1247 2010 10.1084/jem.20092140 Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens 

  78. Blood Nizzoli 122 932 2013 10.1182/blood-2013-04-495424 Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses 

  79. J. Exp. Med. Hammad 207 2097 2010 10.1084/jem.20101563 Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen 

  80. J. Immunol. Campbell 186 5468 2011 10.4049/jimmunol.1002923 Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells 

  81. Trends Immunol. Segura 34 440 2013 10.1016/j.it.2013.06.001 Inflammatory dendritic cells in mice and humans 

  82. Immunity Segura 38 336 2013 10.1016/j.immuni.2012.10.018 Human inflammatory dendritic cells induce Th17 cell differentiation 

  83. Immunity Mashayekhi 35 249 2011 10.1016/j.immuni.2011.08.008 CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites 

  84. Nat. Immunol. Satpathy 14 937 2013 10.1038/ni.2679 Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens 

  85. Curr. Opin. Immunol. Briseno 29 69 2014 10.1016/j.coi.2014.04.006 Complementary diversification of dendritic cells and innate lymphoid cells 

  86. Immunity Tussiwand 42 916 2015 10.1016/j.immuni.2015.04.017 Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses 

  87. Immunity Swiecki 33 955 2010 10.1016/j.immuni.2010.11.020 Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual 

  88. Immunity Takagi 35 958 2011 10.1016/j.immuni.2011.10.014 Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo 

  89. Proc. Natl. Acad. Sci. U. S. A. Cervantes-Barragan 109 3012 2012 10.1073/pnas.1117359109 Plasmacytoid dendritic cells control T-cell response to chronic viral infection 

  90. J. Immunol. Swiecki 192 4409 2014 10.4049/jimmunol.1303135 Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells 

  91. Proc. Natl. Acad. Sci. U. S. A. Bar-On 107 14745 2010 10.1073/pnas.1001562107 CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells 

  92. Immunity Jung 17 211 2002 10.1016/S1074-7613(02)00365-5 D.R. Littman and R.A. Lang, in vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens 

  93. J. Exp. Med. Postigo 174 1313 1991 10.1084/jem.174.6.1313 Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18 

  94. J. Exp. Med. Guilliams 210 1977 2013 10.1084/jem.20131199 Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF 

  95. Biochem. Pharmacol. You 86 836 2013 10.1016/j.bcp.2013.07.006 Role of hepatic resident and infiltrating macrophages in liver repair after acute injury 

  96. J. Exp. Med. Meredith 209 1153 2012 10.1084/jem.20112675 Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage 

  97. J. Immunol. Methods Loschko 434 32 2016 10.1016/j.jim.2016.04.004 Inducible targeting of cDCs and their subsets in vivo 

  98. Trends Immunol. Sozzani 31 270 2010 10.1016/j.it.2010.05.004 Trafficking properties of plasmacytoid dendritic cells in health and disease 

  99. Am. J. Pathol. Farkas 159 237 2001 10.1016/S0002-9440(10)61689-6 Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions 

  100. J. Immunol. Lande 173 2815 2004 10.4049/jimmunol.173.4.2815 Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis 

  101. J. Exp. Med. Nestle 202 135 2005 10.1084/jem.20050500 Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production 

  102. J. Immunol. Penna 167 1862 2001 10.4049/jimmunol.167.4.1862 Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells 

  103. J. Immunol. Krug 169 6079 2002 10.4049/jimmunol.169.11.6079 IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation 

  104. J. Exp. Med. Vanbervliet 198 823 2003 10.1084/jem.20020437 The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12 

  105. J. Immunol. Kohrgruber 173 6592 2004 10.4049/jimmunol.173.11.6592 Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands 

  106. J. General Virol. Cicinnati 89 1243 2008 10.1099/vir.0.83517-0 Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon 

  107. Transplantation Cicinnati 88 504 2009 10.1097/TP.0b013e3181b0e608 Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells 

  108. Blood Schnurr 103 1391 2004 10.1182/blood-2003-06-1959 Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells 

  109. J. Immunol. Devosse 182 4974 2009 10.4049/jimmunol.0803128 Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils 

  110. J. Investig. Dermatol. Gutzmer 126 2422 2006 10.1038/sj.jid.5700416 Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a 

  111. Blood Kaser 103 648 2004 10.1182/blood-2002-07-2322 Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression 

  112. J. Exp. Med. Vermi 201 509 2005 10.1084/jem.20041310 Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin 

  113. J. Exp. Med. Zabel 205 2207 2008 10.1084/jem.20080300 Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis 

  114. J. Exp. Med. Albanesi 206 249 2009 10.1084/jem.20080129 Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment 

  115. Blood Parolini 109 3625 2007 10.1182/blood-2006-08-038844 The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues 

  116. PloS One Graham 9 e112925 2014 10.1371/journal.pone.0112925 A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease 

  117. J. Autoimmun. Duraes 67 8 2016 10.1016/j.jaut.2015.08.014 pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation 

  118. Nat. Rev. Immunol. Worbs 17 30 2017 10.1038/nri.2016.116 Dendritic cell migration in health and disease 

  119. Hum. Immunol. Gill 63 1172 2002 10.1016/S0198-8859(02)00756-5 Blood dendritic cells and DC-poietins in systemic lupus erythematosus 

  120. Clin. Exp. Immunol. Migita 142 84 2005 10.1111/j.1365-2249.2005.02897.x Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus 

  121. Lupus Jin 17 654 2008 10.1177/0961203308089410 Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression 

  122. Arthritis Res. Ther. Jongbloed 8 R15 2006 10.1186/ar1864 Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis 

  123. J. Exp. Med. Power 186 825 1997 10.1084/jem.186.6.825 Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells 

  124. J. Pathol. Page 204 28 2004 10.1002/path.1607 Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression 

  125. Arthritis Rheum. Page 50 199 2004 10.1002/art.11428 Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells 

  126. J. Immunol. Page 168 5333 2002 10.4049/jimmunol.168.10.5333 Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium 

  127. Am. J. Pathol. Noort 185 1935 2015 10.1016/j.ajpath.2015.03.012 Tertiary lymphoid structures in rheumatoid arthritis: NF-kappaB-Inducing kinase-positive endothelial cells as central players 

  128. J. Immunol. Rodriguez-Pla 192 5586 2014 10.4049/jimmunol.1301319 IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes 

  129. Nat. Med. Clatworthy 20 1458 2014 10.1038/nm.3709 Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes 

  130. Cytokine & Growth Factor Rev. Bondue 22 331 2011 10.1016/j.cytogfr.2011.11.004 Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism 

  131. Arthritis Res. Ther. Kaneko 13 R158 2011 10.1186/ar3475 Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis 

  132. Exp. Mol. Pathol. Eisinger 92 90 2012 10.1016/j.yexmp.2011.10.006 Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis 

  133. Kidney Int. De Palma 79 1228 2011 10.1038/ki.2011.32 The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis 

  134. Autoimmunity Sozzani 43 196 2010 10.3109/08916930903510872 Type I interferons in systemic autoimmunity 

  135. Nat. Rev. Immunol. Gilliet 8 594 2008 10.1038/nri2358 Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases 

  136. Autoimmunity Pisetsky 40 281 2007 10.1080/08916930701358826 The origin of extracellular DNA during the clearance of dead and dying cells 

  137. Front. Immunol. Yang 7 302 2016 10.3389/fimmu.2016.00302 New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation 

  138. Curr. Opin. Rheumatol. Smith 27 448 2015 10.1097/BOR.0000000000000197 The role of neutrophils in the pathogenesis of systemic lupus erythematosus 

  139. Nature Lande 449 564 2007 10.1038/nature06116 Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide 

  140. Sci. Transl. Med. Lande 3 73ra19 2011 10.1126/scitranslmed.3001180 Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus 

  141. Eur. J. Immunol. Lande 45 203 2015 10.1002/eji.201344277 Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA 

  142. J. Biol. Chem. Sandgren 279 17951 2004 10.1074/jbc.M311440200 The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis 

  143. Nat. Immunol. Tian 8 487 2007 10.1038/ni1457 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE 

  144. Nat. Med. Diana 19 65 2013 10.1038/nm.3042 Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes 

  145. Arthritis Rheum. Lovgren 50 1861 2004 10.1002/art.20254 Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG 

  146. J. Exp. Med. Barrat 202 1131 2005 10.1084/jem.20050914 Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus 

  147. J. Clin. Investig. Means 115 407 2005 10.1172/JCI23025 Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 

  148. Immunity Henault 37 986 2012 10.1016/j.immuni.2012.09.014 Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes 

  149. Autoimmun. Rev. Chan 11 890 2012 10.1016/j.autrev.2012.03.004 Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus 

  150. Arthritis Rheum. Bave 52 1185 2005 10.1002/art.20998 Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism 

  151. Arthritis Rheum. Eloranta 56 3112 2007 10.1002/art.22860 A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies 

  152. Ann. Rheum. Dis. Eloranta 69 1396 2010 10.1136/ard.2009.121400 Type I interferon system activation and association with disease manifestations in systemic sclerosis 

  153. J. Exp. Med. Ganguly 206 1983 2009 10.1084/jem.20090480 Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 

  154. J. Exp. Med. Vollmer 202 1575 2005 10.1084/jem.20051696 Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 

  155. Semin. Immunol. Christensen 19 11 2007 10.1016/j.smim.2006.12.005 Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors 

  156. Front. Genet. Turchinovich 4 119 2013 10.3389/fgene.2013.00119 Circulating miRNAs: cell-cell communication function? 

  157. Proc. Natl. Acad. Sci. U. S. A. Fabbri 109 E2110 2012 10.1073/pnas.1209414109 MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response 

  158. Nat. Neurosci. Lehmann 15 827 2012 10.1038/nn.3113 An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration 

  159. Autoimmun. Rev. Chen 15 1171 2016 10.1016/j.autrev.2016.09.003 The role of microRNAs in the pathogenesis of autoimmune diseases 

  160. Oncotarget Wang 8 5498 2017 10.18632/oncotarget.12534 Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature 

  161. Nat. Med. Kortylewski 11 1314 2005 10.1038/nm1325 Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity 

  162. Arthritis Rheum. Hartgring 63 1878 2011 10.1002/art.30336 Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis 

  163. Arthritis Rheumatol. Moret 66 1176 2014 10.1002/art.38338 Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells 

  164. Arthritis Rheum. van Roon 52 1700 2005 10.1002/art.21045 Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages 

  165. Arthritis Res. Ther. Moret 16 497 2014 10.1186/s13075-014-0497-x Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions 

  166. Ann. Rheum. Dis. Reynolds 75 899 2016 10.1136/annrheumdis-2014-206578 Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis 

  167. Proc. Natl. Acad. Sci. U. S. A. Lee 102 15995 2005 10.1073/pnas.0508122102 The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation 

  168. Immunity Kim 27 321 2007 10.1016/j.immuni.2007.06.010 Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes 

  169. Proc. Natl. Acad. Sci. U. S. A. Desnues 111 1497 2014 10.1073/pnas.1314121111 TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice 

  170. Immunity Teichmann 38 528 2013 10.1016/j.immuni.2012.11.017 Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus 

  171. Proc. Natl. Acad. Sci. U. S. A. Lamagna 110 E3311 2013 10.1073/pnas.1300617110 Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation 

  172. Arthritis Rheum. Tada 63 738 2011 10.1002/art.30183 Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice 

  173. Immunity Kool 35 82 2011 10.1016/j.immuni.2011.05.013 The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity 

  174. Blood Chen 109 4360 2007 10.1182/blood-2006-11-056424 Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity 

  175. Proc. Natl. Acad. Sci. U. S. A. Celhar 112 E6195 2015 10.1073/pnas.1507052112 RNA sensing by conventional dendritic cells is central to the development of lupus nephritis 

  176. Ann. Rheum. Dis. Jensen 72 596 2013 10.1136/annrheumdis-2012-202024 Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients 

  177. Arthritis Rheum. Xie 63 2425 2011 10.1002/art.30420 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner 

  178. Mol. Immunol. Csomor 44 3389 2007 10.1016/j.molimm.2007.02.014 Complement protein C1q induces maturation of human dendritic cells 

  179. Mol. Immunol. Teh 48 1128 2011 10.1016/j.molimm.2011.02.006 C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation 

  180. Immunity Stranges 26 629 2007 10.1016/j.immuni.2007.03.016 Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity 

  181. J. Immunol. Chen 187 5684 2011 10.4049/jimmunol.1101834 Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells 

  182. Nat. Immunol. Ramirez-Ortiz 14 917 2013 10.1038/ni.2670 The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity 

  183. Proc. Natl. Acad. Sci. U. S. A. Wohn 110 10723 2013 10.1073/pnas.1307569110 Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice 

  184. J. Immunol. Decker 174 3326 2005 10.4049/jimmunol.174.6.3326 Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation 

  185. J. Immunol. Kis-Toth 187 1222 2011 10.4049/jimmunol.1100469 Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response 

  186. J. Mol. Med. Eloranta 94 1103 2016 10.1007/s00109-016-1421-4 Cause and consequences of the activated type I interferon system in SLE 

  187. J. Rheumatol. Ytterberg 10 906 1983 Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC 

  188. Lupus Blomberg 10 484 2001 10.1191/096120301678416042 Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus 

  189. J. Exp. Med. Bennett 197 711 2003 10.1084/jem.20021553 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood 

  190. Arthritis Rheum. Hjelmervik 52 1534 2005 10.1002/art.21006 Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects 

  191. Immunol. Rev. Baechler 210 120 2006 10.1111/j.0105-2896.2006.00367.x Gene expression profiling in human autoimmunity 

  192. Ann. Rheum. Dis. Higgs 70 2029 2011 10.1136/ard.2011.150326 Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway 

  193. J. Interferon Res. Schmid 14 229 1994 10.1089/jir.1994.14.229 The type I interferon system is locally activated in psoriatic lesions 

  194. PloS One Yao 3 e2737 2008 10.1371/journal.pone.0002737 Type I interferon: potential therapeutic target for psoriasis? 

  195. J. Exp. Med. Joo 209 1335 2012 10.1084/jem.20111644 Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation 

  196. Proc. Natl. Acad. Sci. U. S. A. Li 105 12439 2008 10.1073/pnas.0806439105 Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice 

  197. J. Investig. Dermatol. Wollenberg 119 1096 2002 10.1046/j.1523-1747.2002.19515.x Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases 

  198. J. Exp. Med. Dzionek 194 1823 2001 10.1084/jem.194.12.1823 BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction 

  199. Diabetes Sobel 47 1867 1998 10.2337/diabetes.47.12.1867 Alpha-interferon inhibits the development of diabetes in NOD mice 

  200. Life Sci. Sobel 62 1293 1998 10.1016/S0024-3205(98)00063-0 Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats 

  201. J. Interferon & Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. Tanaka-Kataoka 19 877 1999 10.1089/107999099313398 Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice 

  202. Exp. Biol. Med. Brod 227 981 2002 10.1177/153537020222701105 Ingested type I interferon: state of the art as treatment for autoimmunity 

  203. Arterioscler., Thromb., Vasc. Biol. Macritchie 32 2569 2012 10.1161/ATVBAHA.112.251314 Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice 

  204. Proc. Natl. Acad. Sci. U. S. A. Baccala 110 2940 2013 10.1073/pnas.1222798110 Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus 

  205. J. Exp. Med. Sisirak 211 1969 2014 10.1084/jem.20132522 Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus 

  206. J. Exp. Med. Rowland 211 1977 2014 10.1084/jem.20132620 Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model 

  207. Mult. Scler. Goodkin 1 321 1996 10.1177/135245859600100605 Interferon beta treatment for multiple sclerosis: persisting questions 

  208. Cytokine & Growth Factor Rev. Annibali 26 221 2015 10.1016/j.cytogfr.2014.10.010 IFN-beta and multiple sclerosis: from etiology to therapy and back 

  209. Immunity Prinz 28 675 2008 10.1016/j.immuni.2008.03.011 Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system 

  210. Immunotherapy von Glehn 4 1053 2012 10.2217/imt.12.117 Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis 

  211. Eur. J. Immunol. Isaksson 39 2925 2009 10.1002/eji.200839179 Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE 

  212. J. Immunol. Bailey-Bucktrout 180 6457 2008 10.4049/jimmunol.180.10.6457 Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis 

  213. Nat. Immunol. Bailey 8 172 2007 10.1038/ni1430 CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE 

  214. J. Exp. Med. Irla 207 1891 2010 10.1084/jem.20092627 MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity 

  215. Am. J. Pathol. Lebre 172 940 2008 10.2353/ajpath.2008.070703 Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles 

  216. Arthritis Rheum. Tournadre 64 533 2012 10.1002/art.33350 Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation 

  217. Arthritis Res. Ther. Moret 15 R155 2013 10.1186/ar4338 Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity 

  218. Nat. Rev. Rheumatol. Takayanagi 5 667 2009 10.1038/nrrheum.2009.217 Osteoimmunology and the effects of the immune system on bone 

  219. Ann. Rheum. Dis. Hot 70 727 2011 10.1136/ard.2010.143768 Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes 

  220. Blood Rivollier 104 4029 2004 10.1182/blood-2004-01-0041 Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment 

  221. BMB Rep. Kim 47 60 2014 10.5483/BMBRep.2014.47.2.014 The pathophysiological role of dendritic cell subsets in psoriasis 

  222. Proc. Natl. Acad. Sci. U. S. A. Lowes 102 19057 2005 10.1073/pnas.0509736102 Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a) 

  223. Nat. Med. Greter 11 328 2005 10.1038/nm1197 Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis 

  224. Proc. Natl. Acad. Sci. U. S. A. Poppensieker 109 3897 2012 10.1073/pnas.1114153109 CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells 

  225. Nat. Immunol. Codarri 12 560 2011 10.1038/ni.2027 RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation 

  226. Nat. Immunol. El-Behi 12 568 2011 10.1038/ni.2031 The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF 

  227. Am. J. Respir. Cell Mol. Biol. Zaba 42 32 2010 10.1165/rcmb.2009-0033TR Dendritic cells in the pathogenesis of sarcoidosis 

  228. Eur. Respir. J. Lommatzsch 30 878 2007 10.1183/09031936.00036307 Airway dendritic cell phenotypes in inflammatory diseases of the human lung 

  229. J. Immunol. Shigehara 166 642 2001 10.4049/jimmunol.166.1.642 IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs 

  230. Nature Maloy 474 298 2011 10.1038/nature10208 Intestinal homeostasis and its breakdown in inflammatory bowel disease 

  231. Eur. J. Immunol. Benedetti 44 339 2014 10.1002/eji.201344184 Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis 

  232. J. Rheumatol. Prevosto 39 1918 2012 10.3899/jrheum.120208 Cytokine secretion by pathogen recognition receptor-stimulated dendritic cells in rheumatoid arthritis and ankylosing spondylitis 

  233. J. Autoimmun. Gravano 45 68 2013 10.1016/j.jaut.2013.06.004 Promotion and prevention of autoimmune disease by CD8+ T cells 

  234. J. Clin. Investig. Drobits 122 575 2012 10.1172/JCI61034 Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells 

  235. J. Immunol. Chaperot 176 248 2006 10.4049/jimmunol.176.1.248 Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells 

  236. J. Immunol. Kalb 188 1583 2012 10.4049/jimmunol.1102437 TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity 

  237. Immunobiology Riboldi 214 868 2009 10.1016/j.imbio.2009.06.016 Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells 

  238. Br. J. Dermatol. Zahn 165 1118 2011 10.1111/j.1365-2133.2011.10479.x Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus 

  239. Blood Karrich 121 3103 2013 10.1182/blood-2012-08-452995 IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation 

  240. J. Investig. Dermatol. Salvi 137 1493 2017 10.1016/j.jid.2017.03.016 IL-21 may promote granzyme B-Dependent NK/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus 

  241. Nat. Med. Caruso 15 1013 2009 10.1038/nm.1995 Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 

  242. J. Br. Soc. Allergy Clin. Immunol. Bratke 40 1015 2010 Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation, Clinical and experimental allergy 

  243. Lancet Wahren-Herlenius 382 819 2013 10.1016/S0140-6736(13)60954-X Immunopathogenic mechanisms of systemic autoimmune disease 

  244. Lab. Investig.; a J. Tech. Methods Pathol. Boivin 89 1195 2009 10.1038/labinvest.2009.91 Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma 

  245. Acta Pharmacol. Sin. Wu 36 1395 2015 10.1038/aps.2015.91 Toll-like receptors: potential targets for lupus treatment 

  246. Nat. Rev. Rheumatol. Coutant 12 703 2016 10.1038/nrrheum.2016.147 Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles 

  247. Diabetes Care Giannoukakis 34 2026 2011 10.2337/dc11-0472 Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients 

  248. Immunotherapy Giannoukakis 5 919 2013 10.2217/imt.13.89 Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood 

  249. Sci. Transl. Med. Benham 7 290ra87 2015 10.1126/scitranslmed.aaa9301 Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients 

  250. Ann. Rheum. Dis. Bell 76 227 2017 10.1136/annrheumdis-2015-208456 Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis 

  251. Scand. J. Immunol. Figueroa-Vega 64 668 2006 10.1111/j.1365-3083.2006.01849.x Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus 

  252. Immunology Wu 149 48 2016 10.1111/imm.12628 Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro 

  253. Autoimmun. Rev. Mackern-Oberti 14 127 2015 10.1016/j.autrev.2014.10.010 Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases 

  254. J. Immunol. Res. Lee 2016 5392623 2016 Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on dendritic cells promote Induction of T Cell hyporesponsiveness to myelin-derived antigens 

  255. J. Immunol. Sozzani 155 3292 1995 10.4049/jimmunol.155.7.3292 Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines 

  256. Arthritis Rheumatol. Wang 67 2403 2015 10.1002/art.39211 PTPN22 variant R620W is associated with reduced toll-like receptor 7-induced type I interferon in systemic lupus erythematosus 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로